Monday, May 27, 2013 5:36:53 AM
try ssingh@vistagen.com or jdotson@vistagen.com with your legitimate questions. Certainly, if fraud is embarked upon, the responsible parties should be called to task.
False press releases based upon no due diligence work should certainly be of interest to the SEC. The whole Sarbanes Oxley laws are designed to prevent fraudulent activities. Enron was 2001 - where are the authorities today in protecting us from blatant ripoffs? Or is this too small a deal to simply count? Of course, Shawn and Jerry will hide behind "we are a public company and can't tell you anything privileged."
Push as hard as you can. I have no wish to see those that flaunt the laws of the land continue to prosper. Particularly when those who shouldn't suffer, do.
False press releases based upon no due diligence work should certainly be of interest to the SEC. The whole Sarbanes Oxley laws are designed to prevent fraudulent activities. Enron was 2001 - where are the authorities today in protecting us from blatant ripoffs? Or is this too small a deal to simply count? Of course, Shawn and Jerry will hide behind "we are a public company and can't tell you anything privileged."
Push as hard as you can. I have no wish to see those that flaunt the laws of the land continue to prosper. Particularly when those who shouldn't suffer, do.
Recent VTGN News
- Vistagen Receives FDA “Study May Proceed” Letter Under its Refisolone IND Application, Enabling Further Phase 2 Clinical Development for the Treatment of Vasomotor Symptoms (Hot Flashes) due to Menopause • Business Wire • 04/22/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 09:27:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 12:43:16 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 12:41:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 12:40:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 12:33:03 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:16:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2026 08:45:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 08:10:38 PM
- Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN • PR Newswire (US) • 03/16/2026 06:38:00 AM
- Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN • PR Newswire (US) • 03/12/2026 07:29:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2026 11:02:20 AM
- Contact The Gross Law Firm by March 16, 2026 Deadline to Join Class Action Against Vistagen Therapeutics, Inc.(VTGN) • PR Newswire (US) • 03/10/2026 01:00:00 PM
- Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN • PR Newswire (US) • 03/09/2026 07:35:00 AM
- Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN • PR Newswire (US) • 03/06/2026 09:29:00 AM
- The Gross Law Firm Notifies Vistagen Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - VTGN • PR Newswire (US) • 03/03/2026 02:00:00 PM
- Vistagen to Participate in Upcoming Investor Conferences • Business Wire • 03/03/2026 01:30:00 PM
- Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN • PR Newswire (US) • 03/02/2026 07:55:00 AM
- Vistagen to Participate in the 46th Annual TD Cowen Healthcare Conference • Business Wire • 02/25/2026 01:30:00 PM
- Class Action Filed Against Vistagen Therapeutics, Inc. (VTGN) - March 16, 2026 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 02/24/2026 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 02:12:03 PM
- Shareholders that lost money on Vistagen Therapeutics, Inc.(VTGN) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 02/19/2026 02:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 09:26:03 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 03:02:23 PM
